# reload+after+2024-01-22 16:44:24.779899
address1§7 Times Square
address2§43rd Floor
city§New York
state§NY
zip§10036
country§United States
phone§929-999-4055
website§https://dianthustx.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Dianthus Therapeutics, Inc. operates as a clinical-stage biotechnology company that designs, develops, and delivers novel monoclonal antibodies for people living with severe autoimmune and inflammatory diseases. It develops DNTH103 that is in phase 1 clinical trails in patients with generalized myasthenia gravis, multifocal motor neuropathy, and chronic inflammatory demyelinating polyneuropathy. Dianthus Therapeutics, Inc. was incorporated in 2015 and is based in New York, New York.
fullTimeEmployees§32
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Marino  Garcia M.B.A.', 'age': 57, 'title': 'President, CEO, Secretary & Director', 'yearBorn': 1966, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Ryan  Savitz', 'title': 'CFO & Treasurer', 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Edward G. Carr', 'age': 54, 'title': 'Chief Accounting Officer', 'yearBorn': 1969, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Judson  Taylor', 'title': 'Head of Technical Operations', 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Jeffrey  Stavenhagen Ph.D.', 'title': 'Chief Scientific Officer', 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Jennifer Davis Ruff', 'title': 'VP and Head of Investor Relations & Corporate Affairs.', 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Adam M. Veness Esq.', 'age': 37, 'title': 'General Counsel', 'yearBorn': 1986, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Kristina  Maximenko', 'title': 'Chief People Officer', 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Simrat  Randhawa M.B.A., M.D.', 'title': 'Chief Medical Officer', 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Rashieda  Gluck', 'title': 'Head of Clinical Development Operations', 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§4
boardRisk§4
compensationRisk§8
shareHolderRightsRisk§10
overallRisk§7
governanceEpochDate§1704067200
maxAge§86400
priceHint§2
payoutRatio§0.0
priceToSalesTrailing12Months§53.81069
currency§USD
dateShortInterest§1702598400
forwardEps§-3.64
exchange§NCM
quoteType§EQUITY
shortName§Dianthus Therapeutics, Inc.
longName§Dianthus Therapeutics, Inc.
firstTradeDateEpochUtc§1529587800
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§1c256785-fa9a-34f5-a846-6abff7f6272e
gmtOffSetMilliseconds§-18000000
targetHighPrice§45.0
targetLowPrice§23.0
targetMeanPrice§30.67
targetMedianPrice§24.0
recommendationMean§1.3
recommendationKey§strong_buy
numberOfAnalystOpinions§3
quickRatio§14.575
grossMargins§1.0
ebitdaMargins§0.0
trailingPegRatio§None
